Intra-articular injection of botulinum toxin type A in hemiplegic shoulder pain: a multicentric, double blind randomised, versus steroid study. - BTX-A in HSP

FONDAZIONE ISTITUTO SAN RAFFAELE-G.GIGLIO0 个研究点开始时间: 2012年3月8日最近更新: 2012年8月28日

适应症

试验速览

暂无简介。

•Patients with hemiparesis and shoulder pain due to first stroke (ischemic or hemorrhagic) admitted in a rehabilitative department to carry out a standard post-acute rehabilitative program.
•Age 18-70 years.
•Pain score of 45 or greater on a 0-100 mm pain visual analog scale (VAS; 0 = no pain, 100 = worst possible pain).
•Duration of HSP for at least one month.
•Pain refractoriness to conventional treatment i.e. common analgesics (such as paracetamol and NSAIDs), slings, strapping and handling of the arm, functional electrical stimulation of shoulder muscles.
•Are the trial subjects under 18? no
•Number of subjects for this age range: 0
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 26
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 26

•Significant spasticity in the upper shoulder joint, defined as a score of 2 or more at the modified Ashworth scale.
•History of shoulder pain or shoulder diseases.
•History of neurological diseases (i.e. Parkinson disease, dystonia).
•History of botulinum toxin treatment.

发起方

FONDAZIONE ISTITUTO SAN RAFFAELE-G.GIGLIO